Stryker (SYK) Long-Term Debt Repayments (2018 - 2026)
Stryker's (SYK) quarterly Long-Term Debt Repayments came in at $1.0 billion in Q1 2026, up 33.33% on a QoQ basis from $750.0 million in Q4 2025.
Stryker (SYK) Long-Term Debt Repayments (2018 - 2026) Analysis & Trends
Stryker (SYK) has 9 years of Long-Term Debt Repayments data on file, last reported at $1.0 billion in Q1 2026.
- On a quarterly basis, Long-Term Debt Repayments changed N/A year-over-year to $1.0 billion in Q1 2026; TTM through Mar 2026 was $2.4 billion, a 17.7% increase from a year earlier, with the FY2025 full-year figure at $1.4 billion, down 31.34% from the prior year.
- Long-Term Debt Repayments for Q1 2026 stood at $1.0 billion, up from $750.0 million in the prior quarter.
- Over the last five years, Long-Term Debt Repayments for SYK reached as high as $1.4 billion in Q4 2024 and fell as low as $1.0 million in Q3 2024.
- Historically, Long-Term Debt Repayments has averaged $550.0 million across 5 years, with a median of $600.0 million in 2024.
- Across the five-year window, Long-Term Debt Repayments soared 698.68% in 2023 and sank 99.85% in 2024, its largest moves.
- Year by year, Long-Term Debt Repayments stood at $151.0 million in 2022, then surged by 698.68% to $1.2 billion in 2023, then rose by 19.24% to $1.4 billion in 2024, then plunged by 47.84% to $750.0 million in 2025, then soared by 33.33% to $1.0 billion in 2026.
- Per Business Quant data, the three most recent Long-Term Debt Repayments figures were $1.0 billion in Q1 2026, $750.0 million in Q4 2025, and $650.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn | 1.42 Bn |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn | 1.00 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn | - |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn | -64.39 Mn |
| 10 | Steris | 21.34 Bn | 20.90 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Bn |
| Mar 31, 2026 | 1.00 Bn |
| Dec 31, 2025 | 750.00 Mn |
| Dec 31, 2025 | 750.00 Mn |
| Jun 30, 2025 | 650.00 Mn |
| Jun 30, 2025 | 650.00 Mn |
| Dec 31, 2024 | 1.44 Bn |
| Dec 31, 2024 | 1.44 Bn |
| Sep 30, 2024 | 1.00 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 600.00 Mn |
| Jun 30, 2024 | 600.00 Mn |
| Dec 31, 2023 | 1.21 Bn |
| Dec 31, 2023 | 1.21 Bn |
| Sep 30, 2023 | 651.00 Mn |
| Sep 30, 2023 | 651.00 Mn |
| Jun 30, 2023 | 101.00 Mn |
| Jun 30, 2023 | 101.00 Mn |
| Mar 31, 2023 | 100.00 Mn |
| Mar 31, 2023 | 100.00 Mn |